Document:

<PAGE>

                                                                    EXHIBIT 4.25

THE SECURITIES REPRESENTED BY THIS WARRANT AND ISSUABLE UPON EXERCISE HEREOF
HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "1933 ACT"), OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE
SECURITIES LAWS, BUT MAY BE ACQUIRED BY THE REGISTERED HOLDER HEREOF FOR
PURPOSES OF INVESTMENT AND IN RELIANCE ON STATUTORY EXEMPTIONS UNDER THE 1933
ACT AND UNDER ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES AND THE
SECURITIES ISSUED UPON EXERCISE HEREOF MAY NOT BE SOLD, PLEDGED, TRANSFERRED OR
ASSIGNED, NOR MAY THIS WARRANT BE EXERCISED, EXCEPT IN A TRANSACTION WHICH IS
EXEMPT UNDER PROVISIONS OF THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS
OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT.

                WARRANT TO PURCHASE 50,000 SHARES OF COMMON STOCK

      1. GRANT OF WARRANT.

            1.1 SinoFresh HealthCare, Inc., a Florida corporation (the
"Company"), hereby agrees that TIM KEPLER or registered assigns thereof (the
"Holder") is entitled, subject to the provisions of this Warrant, to purchase
from the Company Fifty Thousand (50,000) fully paid and non-assessable shares of
Common Stock, at a price of Four and No/100 ($4.00) per share (the "Exercise
Price"). This Warrant expires at 5:00 p.m. Eastern Time on November 6, 2005 (the
"Expiration Date").

            1.2 The term "Common Stock" means the Common Stock, no par value per
share, of the Company as constituted on the date hereof, together with any other
equity securities that may be issued by the Company in substitution therefore.
The number of shares of Common Stock to be received upon the exercise of this
Warrant and the Exercise Price may be adjusted from time to time as hereinafter
set forth. The shares of Common Stock deliverable upon such exercise, and as
adjusted from time to time, are hereinafter referred to as "Warrant Shares." The
term "Company" means and includes the Company as well as (i) any successor
corporation resulting from the merger or consolidation of such corporation with
another corporation, or (ii) any corporation to which such corporation has
transferred its property or assets as an entirety or substantially as an
entirety.

      2. EXERCISE OF WARRANT. Subject to the limitations set forth in Section 5,
this Warrant shall be exercisable immediately until 5:00 p.m. Eastern Time, on
the Expiration Date or, if such day is a day on which banking institutions in
Florida are authorized by law to close, then on the next succeeding day that
shall not be such a day.

      The Holder may exercise this Warrant by presentation and surrender of this
Warrant to the Company at its principal office with the Election to Purchase
Form attached hereto duly executed for the number of shares specified in such
form. The Exercise Price for the Warrant Stock shall be paid in cash or by
check, which shall be delivered to the Company, together with this Warrant,
concurrently with the Election to Purchase Form. Notwithstanding the foregoing,
if the resale of the Warrant Shares is not then registered pursuant to an
effective registration statement under Section 6 hereof, the Holder may exercise
this Warrant by presentation and surrender of this Warrant at its executive
offices together with the Election to Purchase Form indicating the Holder's
intention to effect a cashless exercise, including a calculation of the number
of shares of Common Stock to be issued upon such exercise in accordance with the
terms hereof ("Cashless Exercise"). In the event of a Cashless Exercise, the
Holder shall surrender this Warrant for that number of shares of Common Stock
determined by multiplying the number of Warrant Shares to which it would
otherwise be entitled by a fraction, the numerator of which shall be the

<PAGE>

difference between the (i) Market Price per share of the Common Stock and (ii)
the Exercise Price, and the denominator of which shall be the Market Price. For
purposes of this Cashless Exercise provision, the term "Market Price" shall
mean, (a) the average of the daily closing bid prices on the OTC Electronic
Bulletin Board ("OTCBB") as reported by Bloomberg for the five (5) consecutive
Trading Days immediately preceding the date the Election to Purchase is
delivered to the Company, or (b) if the OTCBB is not the principal trading
market for the Common Stock, the average of the closing bid prices on the
principal trading market for the Common Stock as reported by Bloomberg, or (c)
if the market value cannot be calculated on any of the foregoing basis, the
Market Price shall be determined in good faith by the Company's Board of
Directors. The term "Trading Day" means any day on which the Common Stock is
traded for any period on the OTCBB, or on the principal securities exchange or
other securities market on which the Common Stock is then traded.

      If this Warrant should be exercised in part only, the Company shall, upon
surrender of this Warrant for cancellation, execute and deliver a new Warrant
evidencing the rights of the Holder thereof to purchase the balance of the
shares purchasable hereunder.

      Upon receipt by the Company of this Warrant at its office, or by the stock
transfer agent of the Company at its office, in proper form for exercise, the
Holder shall be deemed to be the holder of record of the shares of Common Stock
issuable upon such exercise, notwithstanding that the stock transfer books of
the Company shall then be closed or that certificates representing such shares
of Common Stock shall not then be actually delivered to the Holder.

      3. RESERVATION OF SHARES. The Company will at all times reserve for
issuance and delivery all shares of Common Stock issuable upon exercise of this
Warrant. All such shares shall be duly authorized and, when issued upon exercise
in compliance with the terms of this Warrant, shall be validly issued, fully
paid and non-assessable.

      4. RESTRICTIONS ON EXERCISE AND TRANSFER.

            4.1 EXERCISE. As a condition to the exercise hereof, the Holder
shall make any truthful representation or warranty reasonably required to
facilitate the application of any exemption(s) from federal and state
registration requirements in connection therewith.

            4.2 HOLDER'S INTENT. The Holder of this Warrant, by acceptance
hereof, represents and warrants to the Company that such Holder is acquiring
this Warrant and the Warrant Shares for investment for the Holder's own account
and not with a view to, or for resale in connection with, any distribution
thereof.

            4.3 TRANSFER. Neither this Warrant nor the Warrant Shares have been
registered under the Act, and none of the foregoing may be sold or transferred
in whole or in part unless the Holder shall have first given notice to the
Company describing such sale or transfer and furnished to the Company an opinion
of counsel (which counsel and opinion (in form and substance) shall be
reasonably satisfactory to the Company) to the effect that the proposed sale or
transfer may be made without registration under the 1933 Act.

            4.4 LEGENDS. Each certificate representing Warrant Shares purchased
hereunder shall bear legends substantially as follows:

            THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
            SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD,
            TRANSFERRED,

                                       2
<PAGE>

            ASSIGNED, PLEDGED, OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER
            SUCH ACT, OR UNLESS THE CORPORATION HAS RECEIVED AN OPINION OF
            COUNSEL OR OTHER EVIDENCE, SATISFACTORY TO THE COMPANY AND ITS
            COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

            THE COMPANY IS AUTHORIZED TO ISSUE MORE THAN ONE CLASS OF STOCK. THE
            COMPANY WILL FURNISH IN WRITING AND WITHOUT CHARGE TO EACH
            SHAREHOLDER WHO SO REQUESTS A STATEMENT OF THE POWERS, DESIGNATIONS,
            PREFERENCES AND RELATIVE PARTICIPATION, OPTIONAL OR OTHER SPECIAL
            RIGHTS OF EACH CLASS OF STOCK AND THE QUALIFICATIONS, LIMITATIONS OR
            RESTRICTION OF SUCH PREFERENCES AND/OR RIGHTS.

      5. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES FOR SUBDIVISION OR
COMBINATION OF COMMON STOCK.

            5.1 ADJUSTMENTS.

                  (1) SUBDIVISION. In the event that the Company at any time or
from time to time after the date of this Warrant shall declare or pay any
dividend on the shares of Common Stock payable in shares of Common Stock or in
any right to acquire shares of Common Stock, or shall effect a subdivision of
the outstanding shares of Common Stock into a greater number of shares of Common
Stock (by stock split, reclassification or otherwise), then the Exercise Price
in effect immediately prior to such event and the number of shares purchasable
hereunder shall, concurrently with the effectiveness of such event, be
proportionately decreased and increased, respectively.

                  (2) COMBINATION. In the event that at any time or from time to
time after the date of this Warrant the outstanding shares of Common Stock shall
be combined or consolidated into a lesser number of shares of Common Stock (by
reclassification or otherwise), then the Exercise Price in effect immediately
prior to such event and the number of shares purchasable hereunder shall,
concurrently with the effectiveness of such event, be proportionately increased
and decreased, respectively.

            5.2 ADJUSTMENT FOR RECLASSIFICATION, EXCHANGE, OR SUBSTITUTION. In
the event of any reorganization or any reclassification of the capital stock of
the Company, any consolidation or merger of the Company with or into another
corporation or corporations or the conveyance of all or substantially all of the
Company's assets to another corporation (except for any such transaction which
is treated as a liquidation, dissolution or winding up of the Company), this
Warrant shall thereafter be exercisable for the number of shares of stock or
other securities or property (including cash) to which a holder of the number of
remaining Shares purchasable hereunder would have been entitled upon the record
date of (or date of, if no record date is fixed) such reorganization,
reclassification, consolidation, merger or conveyance; and, in any case,
appropriate adjustment (as determined by the Board of Directors) shall be made
in the application of the provisions herein set forth with respect to the rights
and interests thereafter of the Holder of this Warrant to the end that the
provisions set forth herein shall thereafter be applicable, as nearly as
equivalent as is practicable, in relation to any shares of stock or the
securities or property (including cash) thereafter deliverable upon the exercise
of this Warrant.

                                       3
<PAGE>

      6. REGISTRATION RIGHTS.

            6.1 "PIGGYBACK REGISTRATION". If the Company at any time after the
date of this Agreement proposes to register any of its securities under the 1933
Act (other than in connection a merger or other transaction utilizing Form S-4,
or pursuant to Form S-8, or other comparable form), the Company shall request
that the managing underwriter (if any) of such underwritten offering include the
Warrant Shares in the registration statement for the underwritten offering in
such registration. The Warrant Shares are sometimes referred to collectively
herein as the "Registrable Securities". If such managing underwriter agrees to
include the Registrable Securities in the registration statement relating to the
underwritten offering, the Company shall at such time give prompt written notice
to Holder of its intention to effect such registration and of such Holder's
right under such proposed registration, and upon the request of Holder delivered
to the Company within five (5) business days after giving such notice (which
request shall specify the Registrable Securities intended to be disposed of by
Holder), the Company shall include such Registrable Securities held by Holder
requested to be included in such registration; provided, however, that:

                  (1) If, at any time after giving such written notice of the
Company's intention to register any of the Holder's Registrable Securities and
prior to the effective date of the registration statement filed in connection
with such registration, the Company shall determine for any reason not to file
the registration statement wherein the Registrable Securities are being
registered or to delay the registration of such Registrable Securities, at its
sole election, the Company may give written notice of such determination to
Holder and thereupon shall be relieved of its obligation to register any
Registrable Securities issued or issuable in connection with such registration
(but not from its obligation to pay registration expenses in connection
therewith or to register the Registrable Securities in a subsequent
registration); and in the case of a determination to delay a registration, the
Company shall thereupon be permitted to delay registering any Registrable
Securities for the same period as the delay in respect of securities being
registered for the Company's own account.

                  (2) If the managing underwriter in an underwritten offering
shall advise the Company that it declines to include a portion or all of the
Registrable Securities requested by the Holder to be included in the
registration statement, then distribution of all or a specified portion of the
Registrable Securities shall be excluded from such registration statement (in
case of an exclusion as to a portion of the Registrable Securities, such portion
to be excluded shall be allocated among such holders and any affiliates of the
Company including securities to be registered in such underwritten offering in
proportion to the respective number of Registrable Securities and other
securities requested to be registered by each such holder and affiliate). In
such event the Company shall give the Holder prompt notice of the number of
Registrable Securities excluded from such registration at the request of the
managing underwriter. No such exclusion shall reduce the securities being
offered by the Company for its own account to be included in such registration
statement.

                  (3) Notwithstanding anything to the contrary stated herein, if
deemed to be in the best interests of the Company due to pending unpublished
material information, the time necessary to complete financial statements, or
other reason deemed appropriate by the Company and counsel to the Company, the
Company shall have the right to delay, terminate or withdraw any registration
initiated by it under this Section 6 prior to the effectiveness of such
registration, whether or not Holder has elected to include Holder's Registrable
Securities in such registration. Under no circumstances shall the Company be
required to conduct any audit of its financial statements other than as is
normally required to satisfy the reporting requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act").

                                       4
<PAGE>

Notwithstanding anything else herein to the contrary, all registration rights
set forth herein are subject to any registration rights granted prior to the
date hereof

            6.2 COOPERATION WITH COMPANY. The Company shall not be required to
include any of the Holder's Registrable Securities in a registration statement
relating to an underwritten offering of the Company's securities unless such
Holder accepts the terms of the underwriting as agreed upon between the Company
and the underwriters selected by it (provided such terms are usual and customary
for selling shareholders) and the Holder agrees to execute and/or deliver such
documents in connection with such registration as the Company or the managing
underwriter may reasonably request. The Holder will cooperate with the Company
in all respects in connection with this Warrant, including, timely supplying all
information reasonably requested by the Company and executing and returning all
documents reasonably requested in connection with the registration and sale of
the Registrable Securities.

      7. REGISTRATION PROCEDURES. If and whenever the Company effects the
registration of any of the Registrable Securities under the 1933 Act pursuant to
Section 6 above, the Company shall (except as otherwise provided in this
Warrant), as expeditiously as possible:

            7.1 prepare and file with the Securities and Exchange Commission
(the "Commission") a registration statement and shall use its best efforts to
cause such registration statement to become effective and remain effective until
the earlier of (i) the termination of the registration statement pursuant to
other registration rights agreements, and (ii) all the Registrable Securities
are sold or become capable of being publicly sold without registration under the
1933 Act;

            7.2 prepare and file with the Commission such amendments and
supplements to such registration statement and the prospectus used in connection
therewith as may be necessary to keep such registration statement effective and
to comply with the provisions of the 1933 Act with respect to the sale or other
disposition of all securities covered by such registration statement (including
prospectus supplements with respect to the sales of securities from time to time
in connection with a registration statement pursuant to Rule 415 of the
Commission);

            7.3 furnish to the Holder such numbers of copies of a summary
prospectus or other prospectus, including a preliminary prospectus or any
amendment or supplement to any prospectus, in conformity with the requirements
of the 1933 Act, and such other documents, as the Holder may reasonably request
in order to facilitate the public sale or other disposition of the securities
owned by the Holder; and

            7.4 notify the Holder of Registrable Securities covered by such
registration statement, at any time when a prospectus relating thereto covered
by such registration statement is required to be delivered under the 1933 Act,
of the happening of any event of which it has knowledge as a result of which the
prospectus included in such registration statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading in the light of the circumstances then existing.

      8. RESTRICTIONS ON TRANSFER OF REGISTRABLE SECURITIES. If an underwriter
of an underwritten offering requests, the Holder agrees that he will not sell,
transfer, assign, hypothecate or otherwise dispose of any of the Registrable
Securities for a period of time requested by the underwriter, not to exceed six
(6) months from the effective date of the registration statement pursuant to
which its Registrable Securities have been registered without the prior written
consent of the underwriter of the Company's public offering.

                                       5
<PAGE>

      9. EXPENSES. All expenses incurred in any registration of the Holder's
Registrable Securities under this Agreement shall be paid by the Company,
including, without limitation, printing expenses, fees and disbursements of
counsel for the Company, expenses of any audits to which the Company shall agree
or which shall be necessary to comply with governmental requirements in
connection with any such registration, all registration and filing fees for the
Holder's Registrable Securities under federal and State securities laws, and
expenses of complying with the securities or blue sky laws of any jurisdictions
pursuant to Section 7(d); provided, however, the Company shall not be liable for
(a) any discounts or commissions to any underwriter or broker/dealer in
connection with the sale of the Registrable Securities; (b) any stock transfer
taxes incurred with respect to Registrable Securities or (c) the fees and
expenses of counsel for Holder.

      10. INDEMNIFICATION. In the event any Registrable Securities are included
in a registration statement pursuant to this Agreement:

            10.1 COMPANY INDEMNITY. Without limitation of any other indemnity
provided to Holder, either in connection with the offering or otherwise, to the
extent permitted by law, the Company shall indemnify and hold harmless Holder,
the affiliates, officers, directors and partners of Holder, any underwriter (as
defined in the 1933 Act) for such Holder, and each person, if any, who controls
such Holder or underwriter (within the meaning of the 1933 Act or the Exchange
Act against any losses, claims, damages or liabilities (joint or several) to
which they may become subject under the 1933 Act, the Exchange Act or other
federal or state law, insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon any of the following
statements, omissions or violations (collectively a "Violation"): (i) any untrue
statement or alleged untrue statement of a material fact contained in such
registration statement including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission or
alleged omission to state therein a material fact required to be stated therein,
or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, (iii) any violation or alleged violation
by the Company of the 1933 Act, the Exchange Act, or any state securities law or
any rule or regulation promulgated under the 1933 Act, the Exchange Act or any
state securities law, and in each case, the Company shall reimburse the Holder,
affiliate, officer or director or partner, underwriter or controlling person for
any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action;
provided, however, that the Company shall not be liable to Holder in any such
case for any such loss, claim, damage, liability or action to the extent that it
arises out of or is based upon a Violation which occurs in reliance upon and in
conformity with written information furnished expressly for use in connection
with such registration by the Holder or any other officer, director or
controlling person thereof

            10.2 HOLDER INDEMNITY. The Holder shall indemnify and hold harmless
the Company, its affiliates, its counsel, officers, directors, shareholders and
representatives, any underwriter (as defined in the 1933 Act) and each person,
if any, who controls the Company or the underwriter (within the meaning of the
1933 Act or the Exchange Act), against any losses, claims, damages, or
liabilities (joint or several) to which they may become subject under the 1933
Act, the Exchange Act or any state securities law, and in each case the Holder
shall reimburse the Company, affiliate, officer or director or shareholder,
underwriter or controlling person for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action; insofar as such losses, claims, damages or
liabilities (or actions and respect thereof) arise out of or are based upon a
Violation which occurs in reliance upon and in conformity with written
information furnished expressly by such Holder or any other officer, director or
controlling person thereof to the Company in connection with the registration of
Registrable Securities. Notwithstanding the above, the Holder's indemnification
shall be limited to the proceeds received by the Holder from the sale of its
securities registered under the registration statement.

                                       6
<PAGE>

            10.3 NOTICE; RIGHT TO DEFEND. Promptly after receipt by an
indemnified party under this Section 10 of notice of the commencement of any
action (including any governmental action), such indemnified party shall, if a
claim in respect thereof is to be made against any indemnifying party under this
Section 10 deliver to the indemnifying party a written notice of the
commencement thereof and the indemnifying party shall have the right to
participate in and if the indemnifying party agrees in writing that it will be
responsible for any costs, expenses judgments, damages and losses incurred by
the indemnified party with respect to such claim, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with counsel
mutually satisfactory to the parties; provided, however, that an indemnified
party shall have the right to retain its own counsel in combination with other
parties who have entered into substantially identical agreements, with the fees
and expenses to be paid by the indemnifying party, if the indemnified party
based upon advice of counsel reasonably believes that representation of such
indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such
indemnified party and any other party represented by such counsel in such
proceeding. The failure to deliver written notice to the indemnifying party
within a reasonable time of the commencement of any such action shall relieve
such indemnifying party of any liability to the indemnified party under this
Agreement only if and to the extent that such failure is prejudicial to its
ability to defend such action, and the omission so to deliver written notice to
the indemnifying party will not relieve it of any liability that it may have to
any indemnified party otherwise than under this Agreement. There can be no
settlement without the indemnifying party's prior consent.

            10.4 CONTRIBUTION. If the indemnification provided for in this
Agreement is held by a court of competent jurisdiction to be unavailable to an
indemnified party with respect to any loss, liability, claim, damage or expense
referred to therein, then the indemnifying party, in lieu of indemnifying such
indemnified party thereunder, shall contribute to the amount paid or payable by
such indemnified party as a result of such loss, liability, claim, damage or
expense in such proportion as is appropriate to reflect the relative fault of
the indemnifying party on the one hand and of the indemnified party on the other
hand in connection with the statements or omissions which resulted in such loss,
liability, claim, damage or expense as well as any other relevant equitable
considerations. The relevant fault of the indemnifying party and the indemnified
party shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission to state a
material fact relates to information supplied by the indemnifying party or by
the indemnified party and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission.
Notwithstanding the foregoing, the amount the Holder shall be obligated to
contribute pursuant to the Agreement shall be limited to an amount equal to the
proceeds to the Holder of the Registrable Securities sold pursuant to the
registration statement which gives rise to such obligation to contribute (less
the aggregate amount of any damages which the Holder has otherwise been required
to pay in respect of such loss, claim, damage, liability or action or any
substantially similar loss, claim, damage, liability or action arising from the
sale of such Registrable Securities).

            10.5 SURVIVAL OF INDEMNITY. The indemnification provided by this
Warrant shall be a continuing right to indemnification and shall survive the
registration and sale of any Registrable Securities by any person entitled to
indemnification hereunder and the expiration or termination of this Warrant.

      11. ASSIGNMENT OF REGISTRATION RIGHTS. The rights of the Holder under this
Warrant, including the rights to cause the Company to register Registrable
Securities, may not be assigned without the written prior consent of the
Company. In the event of any transfer, the transfer will only be permitted if
the transferee agrees to be bound by the provisions of this Warrant.

                                       7
<PAGE>

      12. NOTICES OF RECORD DATE, ETC. The Company shall establish a record date
for the holders of its Common Stock for the purpose of entitling them to receive
any dividend or other distribution, or any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other securities or to
receive any other right:

            12.1 of any capital reorganization of the Company, any
reclassification of the capital stock of the Company, any consolidation or
merger of the Company with or into another corporation, any share exchange for
shares of capital stock of another corporation or any conveyance of all or
substantially all of the assets of the Company to another corporation;

            12.2 of any voluntary or involuntary dissolution, liquidation or
winding up of the Company; or

            12.3 the Company shall enter into a letter of intent or agreement
with respect to a transaction by which all of the outstanding shares of Common
Stock of the Company are to be acquired by a third party; then the Company shall
mail or cause to be mailed to each Holder at the time outstanding a notice
specifying, as the case may be, (A) the date on which a record is to be taken
for the purpose of such dividend, distribution or rights, and stating the amount
and character of such dividend, distribution or rights, (B) the date on which
such reorganization, reclassification, consolidation, merger, conveyance,
dissolution, liquidation or winding up is to take place, and the time, if any is
to be fixed, as to which the holders of record of Common Stock shall be entitled
to exchange their shares for securities or other property deliverable upon the
completion of such transaction, or (C) the closing of the acquisition by a third
party of all of the outstanding shares of Common Stock. Such notice shall be
mailed as soon as practicable after the occurrence or likelihood of such event
is publicly disclosed, but in any event at least twenty (20) business days prior
to the date specified in such notice.

      13. NOTICES. All notices required hereunder must be in writing and shall
be deemed given when telefaxed, delivered personally or within three days after
mailing when mailed by certified or registered mail, return receipt requested,
if to the Company, at 516 Paul Morris Drive, Englewood, FL 34223, Attention:
Chief Financial Officer; and if to the Holder, at _______________________, or at
such other address of which the Company or Holder has been advised by notice
hereunder.

      14. NO RIGHTS AS SHAREHOLDERS. Nothing contained in this Warrant confers
or shall be construed as conferring upon the Holder hereof the right to vote or
to consent or to receive notice as a shareholder in respect of any meetings of
shareholders for the election of directors or any other matter, or as having any
rights whatsoever as a shareholder of the Company.

      15. EXCHANGE AND REPLACEMENT OF CERTIFICATE.

            15.1 This Warrant is exchangeable without expense, upon the
surrender hereof by the registered Holder at the principal office of the
Company, for a new Warrant of like tenor and date representing in the aggregate
the right to purchase the same number of Warrant Shares as are purchasable
hereunder in such denominations as shall be designated by the Holder hereof at
the time of such surrender.

            15.2 Upon receipt by the Company of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of this Warrant,
and, in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and return and cancellation of this Warrant, if
mutilated, the Company will make and deliver a new Warrant of like tenor, in
lieu of this Warrant.

                                       8
<PAGE>

      16. ELIMINATION OF FRACTIONAL INTERESTS. The Company shall not be required
to issue certificates representing fractions of Warrant Shares on the exercise
of this Warrant, nor shall it be required to issue scrip or pay cash in lieu of
fractional interests, it being the intent of the parties that all fractional
interests shall be eliminated.

      17. WITHHOLDING TAXES.

            17.1 Whenever Warrant Shares are to be issued upon the exercise of
this Warrant, the Company shall have the right to require the Holder to remit to
the Company in cash an amount sufficient to satisfy U.S. federal, state and
local withholding tax requirements, if any, prior to the delivery of any
certificate or certificates for such Warrant Shares.

            17.2 Notwithstanding Section 17.1, at the election of a Holder,
subject to the approval of the Board of Directors of the Company, when Warrant
Shares are to be issued upon the exercise of this Warrant, the Holder may tender
to the Company a number of Warrant Shares, or the Company shall withhold a
number of such Warrant Shares, the fair market value of which is sufficient to
satisfy the tax requirements, if any, attributable to such exercise or
occurrence.

      18. APPLICABLE LAW. The Warrant is issued under and shall for all purposes
be governed by and construed in accordance with the internal laws of the State
of Florida, without regard to conflicts of laws principles.

      19. SEVERABILITY. If one or more provisions of the Warrant are held to be
unenforceable under applicable law, such provision shall be excluded from the
Warrant and the balance of the Warrant shall be interpreted as if such provision
were so excluded and shall be enforceable in accordance with its terms.

      20. SUCCESSORS. All of the covenants, agreements, representations and
warranties contained in this Warrant shall bind the parties hereto and their
respective heirs, executors, administrators, distributes, successors and
assigns.

      21. HEADINGS. The headings in this Warrant are intended for convenience
only and shall have no substantive effect.

      NOW THEREFORE, the Company has caused this Warrant to be signed as of and
effective November 7, 2003

                                  SINOFRESH HEALTHCARE, INC.

                                  By:    /s/ Charles Fust
                                  Name:     Charles Fust
                                  Title:    Chairman and Chief Executive Officer

                                       9
<PAGE>

                               TRANSFER OF WARRANT

      For value received _______________________ hereby sells, assigns and
transfers unto _________________________ the right to purchase _______ shares of
Common Stock, no par value per share, of SinoFresh HealthCare, Inc., which
rights are represented by the attached Warrant, and does hereby irrevocably
constitute and appoint ________________ attorney to transfer said rights on the
books of such Corporation.

Dated:______________________________________, ____
In the Presence of
____________________________________________

<PAGE>

                              ELECTION TO PURCHASE

                (To be signed only upon exercise of the Warrant)

TO:   SinoFresh HealthCare. Inc.

The undersigned, hereby irrevocably elects to exercise the purchase rights
represented by the Warrant granted to the undersigned on ______________ and to
purchase thereunder ___________ shares of Common Stock of SinoFresh HealthCare,
Inc. (the "Company") and herewith encloses either payment of $_______________ or
instructions regarding the manner of exercise permitted under Section 2 of the
Warrant, in full payment of the purchase price of such shares being purchased.

Dated:

                              __________________________________________________
                              (Signature must conform in all respects to name of
                              holder as specified on the face of the Warrant)

                              __________________________________________________
                              (Please Print Name)

                              __________________________________________________
                              (Address)

      The Holder hereby represents and warrants to and agrees with the Company
that, if the shares of Common Stock which the Holder hereby subscribes for have
not been effectively registered under the Securities Act of 1933, or any similar
Federal statute in effect at the date of this Election to Purchase, the Holder
is purchasing said shares of Common Stock for his or its own account for
investment, and not with a view to, or for sale in connection with, any
distribution of such shares and without any present intention of distributing or
selling such shares.

Very truly yours,

(Signature of Holder or duly authorized Agent)

                                       2<PAGE>

                                                                   EXHIBIT 10.32

                      STRATEGIC PLANNING SERVICES AGREEMENT

      THIS STRATEGIC PLANNING SERVICES AGREEMENT (this "Agreement") is entered
into as of September 5, 2003 by and between David Macrae, a Florida resident
(the "Consultant"), and SinoFresh HealthCare, Inc., a Delaware Corporation (the
"Company").

      WHEREAS, the Company desires to be assured of the association and services
of the Consultant in order to avail itself of the Consultant's experience,
skills, abilities, knowledge, and background to facilitate long range strategic
planning, business activity, growth and development, and to advise the Company
in business strategic matters and is therefor willing to engage the Consultant
upon the terms and conditions set forth herein;

      WHEREAS, the Consultant agrees to be engaged and retained by the Company
upon the terms and conditions set forth herein.

      NOW, THEREFORE, in consideration of the premises and the covenants,
agreements and obligations set forth herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereby covenant and agree as follows:

      1. Consulting Services. By preparing and submitting periodic reports to
the Company's Board of Directors, the Consultant agrees to provide consulting
services (the "Services") to the Company, including, but not limited to:

            (a) Updating the Company's business plan and strategic forecasting
models;

            (b) Business development assistance including terms of deals and
suggestions during negotiations;

            (c) Sales assistance through the development of business models and
sales strategy;

            (d) Strategic consulting regarding high level product planning,
market development, marketing and public relations planning;

            (e) Introductions to prospective customers for the Company's
products or services; and

            (f) Participation arid attendance at meetings with the Company's
Board of Directors, management, customers, and strategic partners, as requested
by the Company.

      2. Term. The term of this Agreement shall commence as of the date hereof
and shall be effective for a period of three (3) years (the "Term"). This
agreement may be extended the same terms by mutual agreement between the
Consultant and the Company.

      3. Direction, Control and Coordination. The Consultant shall perform the
Services

<PAGE>

under the direction and with the approval of the Company's Chief Executive
Officer.

      4. Dedication of Resources. The Consultant shall devote such time,
attention and energy as is necessary to perform and discharge the Services in an
efficient, trustworthy, and businesslike manner. The Company acknowledges that
the Consultant has other duties outside of its duties under this Agreement.

      5. Standard of Performance. The Consultant shall use his best reasonable
efforts to perform the Services in a professional, efficient and effective
manner. The Consultant shall perform the Services in conjunction and cooperation
with the Company.

      6. Compensation. As compensation for performing the Services, the Company
shall issue to the Consultant a warrant to purchase 100,000 shares of the
Company's common stock at the price of $7.00 per share (the `Warrant"). The
Warrant is attached hereto as Exhibit A.

      7. Expenses. The Company shall reimburse the Consultant for his reasonable
out-of-pocket expenses incurred in connection with the Services. Additionally,
upon request by the Consultant, the Company shall pay for reasonable
out-of-pocket travel related expenses necessary for the Consultant to perform
the Services. The Company must pre-approve any expense that will exceed $100.00.

      8. Confidential Information. The Consultant recognizes and acknowledges
that he has had and will continue to have access to confidential information of
the Company and its affiliates, including, without limitation, information and
knowledge pertaining to products and services offered, inventions, innovations,
designs, ideas, plans, trade secrets, proprietary information, advertising,
distribution and sales methods and systems, and relationships between the
Company and its affiliates and customers, clients, suppliers and others who have
business dealings with the Company and its affiliates ("Confidential
Information"). The Consultant acknowledges that such Confidential Information is
a valuable and unique asset and covenants that he will not, either during or for
five years following the termination of this Agreement, disclose any such
Confidential Information to any person for any reason whatsoever or use such
Confidential Information (except as his duties hereunder may require) without
the prior written authorization of the Company, unless such information is in
the public domain through no fault of the Consultant or except as may be
required by law. Upon the Company's request, the Consultant will return all
tangible materials containing Confidential Information to the Company.

      9. Relationship. This agreement does not create, and shall not be
construed to create, any joint venture or partnership between the parties. No
officer, employee, agent, servant, or independent contractor of the Consultant,
nor their affiliates, shall at any time be deemed to be an employee, agent,
servant, or broker of the Company for any purpose whatsoever solely as a result
of this Agreement. Further, the Consultant shall have no rig authority to assume
or create any obligation or liability, express or implied, on the Company's
behalf, or to bind the Company in any manner whatsoever.

      10. Notices. Any notice required or desired to be given under this
Agreement shall be in writing and shall be deemed given when personally
delivered or sent by certified or

                                       2
<PAGE>

registered mail to the following addresses, or such other address as to which
one party may have notified the other in such manner:

      If to the Company:         SinoFresh HealthCare, Inc.
                                 516 Paul Morris Drive
                                 Englewood, FL 34223

      With a copy to:            David M. Otto
                                 The Otto Law Group, PLLC
                                 900 Fourth Ave., Suite 3410
                                 Seattle, WA 98164

      If to the Consultant:      David Macrae
                                 P.O. Box 1786
                                 Nokomis, FL  34274

      11. Applicable Law. The validity, interpretation and performance of this
Agreement shall be controlled by and construed under the laws of the State of
Florida.

      12. Severability. The invalidity or unenforceability of any provision
hereof shall in no way affect the validity or enforceability of any other
provisions of this Agreement.

      13. Waiver of Breach. The waiver by either party of a breach of any
provision of this Agreement by the other shall not operate or be construed as a
waiver of any subsequent breach by such party. No waiver shall be valid unless
in writing and signed by an authorized officer of the Company or the Consultant.

      14. Binding Effect. This Agreement shall be binding upon the parties and
their respective personal representatives, successors and assigns.

      15. Entire Agreement and Changes. This Agreement contains the entire
understanding of the parties with respect to its subject matter. It may not be
changed orally but only by an agreement in writing signed by the party against
whom enforcement of any waiver, change, modification, extension, or discharge is
sought

      16. Counterparts. This Agreement may be executed in counterparts each of
which shall constitute an original document, and both of which together shall
constitute the same document.

                            [signature page follows]

                                       3
<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement on the day
and year first above written.

                                          THE COMPANY:

                                          SINOFRESH HEALTHCARE, INC.

                                          /s/ Charles A. Fust
                                          --------------------------------------
                                          Charles A. Fust
                                          Chairman and Chief Executive Officer

                                          THE CONSULTANT:

                                          /s/ David Macrae
                                          --------------------------------------
                                          David Macrae

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]